Randomized Controlled Trial to Compare the Efficacy of Low-dose Daily vs Alternate-day Prednisolone in Children With Steroid Dependent and Frequently Relapsing Nephrotic Syndrome: Daily vs Alternate-day Prednisolone in Nephrotic Syndrome
Journal of Pediatric Nephrology · 16.10.2024
DOI: 10.22037/jpn.v11i3.44033 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Pediatric Nephrology, erschienen am 16.10.2024. Verfasst von Zulquar Nain und 1 weiteren Autor:innen.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background and Aim: Tapering alternate-day doses of corticosteroid forms the cornerstoneof the management of steroid-dependent nephrotic syndrome (SDNS) and frequently relapsingnephrotic syndrome nephrotic syndrome (FRNS). This study compares the reduction ofrelapses over a one-year follow-up, using equivalent steroid doses given as either daily oralternate-day therapy.
Methods
This was an open-label, randomized controlled trial. The participants were childrenwith SDNS or FRNS, aged 2-10 years. After remission, steroid doses were tapered until athreshold below 0.75 mg/kg/day. Then, subjects were randomized to one of two arms asfollows: Daily prednisolone at 0.15-0.30 mg/kg/day (intervention arm) or alternate-day doseof 0.5-0.75 mg/kg (control arm). Both groups were compared after 12 months for a reductionin relapse frequency. Secondary outcome measures included time to first relapse, proportionof relapse-free patients, mean steroid dose used, infection episodes, need for alternativemedications, and side effects of corticosteroids.
Results
Median (interquartile range [IQR]) changes in relapse frequency did not differbetween the groups, 0 (IQR: -1.0, 0.25) vs 0 (IQR: 0.0, 1.0) in intervention and control groups,respectively (P=0.46). The mean percentage change in relapse frequency was -18.1±42.4%(negative denotes decreased) in the intervention group and 6.0±26.9% in the control group(P=0.05). The median relapse frequencies during the trial period were 3 (IQR: 2, 3) and 3(IQR: 3, 4) in the intervention group and control groups, respectively (P=0.021). At studycompletion, prednisolone dose was lower in the intervention group, 0.33±0.12 vs 0.40±0.05(P=0.02). Both groups did not differ by other secondary outcome variables.
Conclusion
In patients with SDNS and FRNS, daily low dose (0.15-0.30 mg/kg/day)administration of prednisolone is not superior to conventional alternate-day dosing.
Schlagwörter
Zitieren
APA
Nain, Z., & Afzal, K. (2024). Randomized Controlled Trial to Compare the Efficacy of Low-dose Daily vs Alternate-day Prednisolone in Children With Steroid Dependent and Frequently Relapsing Nephrotic Syndrome: Daily vs Alternate-day Prednisolone in Nephrotic Syndrome. Journal of Pediatric Nephrology. https://doi.org/10.22037/jpn.v11i3.44033
Vancouver
Nain Z, Afzal K. Randomized Controlled Trial to Compare the Efficacy of Low-dose Daily vs Alternate-day Prednisolone in Children With Steroid Dependent and Frequently Relapsing Nephrotic Syndrome: Daily vs Alternate-day Prednisolone in Nephrotic Syndrome. Journal of Pediatric Nephrology. 2024. doi:10.22037/jpn.v11i3.44033
BibTeX
@article{Nain2024,
author = {Nain, Zulquar and Afzal, Kamran},
title = {Randomized Controlled Trial to Compare the Efficacy of Low-dose Daily vs Alternate-day Prednisolone in Children With Steroid Dependent and Frequently Relapsing Nephrotic Syndrome: Daily vs Alternate-day Prednisolone in Nephrotic Syndrome},
journal = {Journal of Pediatric Nephrology},
year = {2024},
doi = {10.22037/jpn.v11i3.44033}
}
EUVIMED